Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib.

Cancer - 15 Nov 2021

Sadaf Alina, Szabo Sara, Ferguson Katelyn, Sorger Joel I, Sumegi Janos, Bridge Julia A, Pressey Joseph G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminopyridines
Share to Lactams
Share to Neoplasms
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pyrazoles

Source

Identifiers

PMID: 34545945
DOI: 10.1002/cncr.33854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib.PMID 34545945Read ↗

Diagnostic and Therapeutic Implications of a FUS :: TFCP2 Fusion and ALK Activation in a Metastatic RhabdomyosarcomaSemantic proximity Read ↗

KIT Oncogenic Mutations: Biologic Insights, Therapeutic Advances, and Future Directions.Semantic proximity Read ↗

Identification of Dual STRN-NTRK2 Rearrangements in a High Grade Sarcoma, With Good Clinical Response to First-line Larotrectinib TherapySemantic proximity Read ↗

Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapySemantic proximity Read ↗

Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma.Semantic proximity Read ↗

FGFR rearrangements: oncogenic drivers and therapeutic targets.Semantic proximity Read ↗

The First Case Treated with Larotrectinib of a Novel TMTC2-NTRK3 Fusion Undifferentiated High-Grade Pleomorphic Sarcoma of the ChestSemantic proximity Read ↗

Mitofusin-2 in cancer: Friend or foe?Semantic proximity Read ↗

Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.Semantic proximity Read ↗

Li-Fraumeni Syndrome: Imaging Features and GuidelinesSemantic proximity Read ↗

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted TherapySemantic proximity Read ↗

Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic PerspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.